Clinical Web Archive

Sign in Subscribe

Neurology

Comparison of the Efficacy and Safety of Rituximab vs. Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Study

Quick Take: Rituximab vs. Natalizumab in RRMS Rituximab emerges as a robust, real-world alternative to Natalizumab for Relapsing-Remitting Multiple Sclerosis (RRMS), offering comparable efficacy with a distinct safety and logistical profile. 💡 Clinical Impact * Mechanistic Insight: B-cell depletion (Rituximab) provides neuroimmunological control comparable to T-cell trafficking blockade (Natalizumab). This reinforces the

Mediterranean diet and gut microbiota: impact on memory and other cognitive functions: a systematic review

Quick Take: The Mediterranean Diet (MedDiet) improves cognitive resilience by modulating the gut-brain axis, offering a validated non-pharmacological pathway to delay neurodegeneration. 💡 Clinical Impact * Mechanistic Synergy: The MedDiet acts as a "prebiotic powerhouse," shifting the gut microbiota toward a profile that reduces systemic inflammation—a primary driver of

Eptinezumab demonstrates durable efficacy in migraine prevention for patients with multiple prior treatment failures, offering a sustained therapeutic option.

💡 Clinical Impact * Addresses a critical unmet need by providing sustained migraine prevention for patients refractory to standard therapies. * Suggests potential for long-term reduction in migraine burden and improved quality of life, which could reduce healthcare utilization. 📊 Evidence Breakdown * Evidence Grade: 6/10 * Analysis: In participants with migraine having failed 2-4

Effect of Modular Training on Self-Management, Disease, and Treatment Adaptation in Individuals With Hypertension: A Randomized Controlled Trial.

Quick Take: Lacosamide demonstrates comparable efficacy and safety to propranolol for episodic migraine prevention, offering a potential alternative for patients intolerant to standard therapies. 💡 Clinical Impact * Provides a potential new therapeutic option for episodic migraine prevention, specifically addressing an unmet need for patients who cannot tolerate or respond to established

Digital health interventions for older adults with subjective cognitive decline or mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials.

OUTPUT: Quick Take: Digital health interventions show early promise for improving cognitive function and quality of life in older adults with subjective cognitive decline or mild cognitive impairment. 💡 Clinical Impact * Offers a non-pharmacological avenue to support cognitive health and well-being in a population often lacking effective interventions. * Suggests a potential